Blueberries Medical Corp
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. It produces psychoactive and non-psychoactive cannabis by-products. The company is based in Vancouver, Canada.
Blueberries Medical Corp (BBRRF) - Net Assets
Latest net assets as of September 2024: $1.23 Million USD
Based on the latest financial reports, Blueberries Medical Corp (BBRRF) has net assets worth $1.23 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.68 Million) and total liabilities ($444.42K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.23 Million |
| % of Total Assets | 73.49% |
| Annual Growth Rate | -59.42% |
| 5-Year Change | -75.9% |
| 10-Year Change | -99.99% |
| Growth Volatility | 216.38 |
Blueberries Medical Corp - Net Assets Trend (2013–2023)
This chart illustrates how Blueberries Medical Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Blueberries Medical Corp (2013–2023)
The table below shows the annual net assets of Blueberries Medical Corp from 2013 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $1.95 Million | +32.58% |
| 2022-12-31 | $1.47 Million | +2.30% |
| 2021-12-31 | $1.43 Million | -63.11% |
| 2020-12-31 | $3.89 Million | -51.83% |
| 2019-12-31 | $8.08 Million | +618.20% |
| 2018-12-31 | $1.12 Million | +1697.56% |
| 2017-12-31 | $-70.38K | +77.65% |
| 2016-12-31 | $-314.91K | -100.00% |
| 2015-12-31 | $21.80 Billion | -15.12% |
| 2014-12-31 | $25.68 Billion | +60.17% |
| 2013-12-31 | $16.03 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Blueberries Medical Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 246445093300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $26.46 Million | 1359.75% |
| Total Equity | $1.95 Million | 100.00% |
Blueberries Medical Corp Competitors by Market Cap
The table below lists competitors of Blueberries Medical Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grosvenor Resource Corp
V:GVR
|
$1.30 Million |
|
Smartphoto Group NV
BR:SMAR
|
$1.30 Million |
|
Optima Prima Metal Sinergi
JK:OPMS
|
$1.30 Million |
|
Banco Mercantil de Investimentos S.A
SA:BMIN3
|
$1.30 Million |
|
Key Alliance Group Bhd
KLSE:0036
|
$1.30 Million |
|
UPHLW
PINK:UPHLW
|
$1.30 Million |
|
PacifiCorp
PINK:PPWLO
|
$1.30 Million |
|
Core Energy Minerals Ltd
F:F1S0
|
$1.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Blueberries Medical Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 1,467,768 to 1,945,941, a change of 478,173 (32.6%).
- Net loss of 1,635,374 reduced equity.
- New share issuances of 1,981,002 increased equity.
- Other factors increased equity by 132,545.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.64 Million | -84.04% |
| Share Issuances | $1.98 Million | +101.8% |
| Other Changes | $132.54K | +6.81% |
| Total Change | $- | 32.58% |
Book Value vs Market Value Analysis
This analysis compares Blueberries Medical Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.17x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $-0.14 | $0.01 | x |
| 2017-12-31 | $-0.01 | $0.01 | x |
| 2018-12-31 | $0.00 | $0.01 | x |
| 2019-12-31 | $0.07 | $0.01 | x |
| 2020-12-31 | $0.03 | $0.01 | x |
| 2021-12-31 | $0.01 | $0.01 | x |
| 2022-12-31 | $0.01 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Blueberries Medical Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -84.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -567.30%
- • Asset Turnover: 0.12x
- • Equity Multiplier: 1.24x
- Recent ROE (-84.04%) is above the historical average (-86.74%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -8.20% | -10.70% | 0.30x | 2.52x | $-2.92 Billion |
| 2014 | 15.86% | 16.94% | 0.36x | 2.64x | $1.50 Billion |
| 2015 | -15.48% | -13.43% | 0.35x | 3.26x | $-5.54 Billion |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-384.44K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.43K |
| 2018 | -142.92% | 0.00% | 0.00x | 1.66x | $-1.72 Million |
| 2019 | -133.59% | -232297.07% | 0.00x | 1.21x | $-11.60 Million |
| 2020 | -127.00% | -7487.51% | 0.01x | 1.87x | $-5.33 Million |
| 2021 | -358.74% | -3709.64% | 0.04x | 2.50x | $-5.29 Million |
| 2022 | -100.01% | -623.44% | 0.07x | 2.29x | $-1.61 Million |
| 2023 | -84.04% | -567.30% | 0.12x | 1.24x | $-1.83 Million |
Industry Comparison
This section compares Blueberries Medical Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $580,491,146
- Average return on equity (ROE) among peers: -45.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Blueberries Medical Corp (BBRRF) | $1.23 Million | -8.20% | 0.36x | $1.30 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $14.78 Million | -64.19% | 0.99x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-241.47K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -329.21% | 0.78x | $194.64 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $37.06 Million | 39.05% | 0.16x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $32.70 Million | -18.88% | 0.16x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.84 |
| Adcock Ingram Holdings Limited (AIHLF) | $4.54 Billion | 14.90% | 0.58x | $85.61 Million |